Chain Drug Review - Boehringer Ingelheim’s Mobic receives FDA clearance
Friday, January 2nd, 2009Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
> The Food and Drug Administration has approved the use of Mobic as a treatment for rheumatoid arthritis. Boehringer Ingelheim Inc. launched the drug four years ago for treating osteoarthritis, the most comm…
